Clinical Trial Update: Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy [NA]

View source ↗

Summary

This clinical trial update describes ongoing enrollment for a study evaluating a standardized surveillance strategy to detect recurrent disease after resection …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: UMC Utrecht | Conditions: Resectable Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Ductal Adenocarcinoma | NA | Status: ENROLLING_BY_INVITATION